ASCO 2018 | A pharmacoeconomic analysis of multiple myeloma treatment

Rafael Fonseca

The treatment of multiple myeloma (MM) can be very costly. Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Rafael Fonseca, MD, of the Mayo Clinic, Phoenix, AZ, discusses whether patients are able to afford medication for MM, whether they face any financial problems, and finally if MM drugs are worth their cost.

Share this video